Insomnia - Pipeline Review, H2 2012 New Report
Insomnia - Pipeline Review, H2 2012, provides an overview of the Insomnia therapeutic pipeline. This report provides information on the therapeutic development for Insomnia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Insomnia. 'Insomnia - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites...
View full press release